Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CHOLINESTERASE INHIBITOR POLYMORPH AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/156360
Kind Code:
A1
Abstract:
A cholinesterase inhibitor polymorph, wherein specifically disclosed are a succinic octahydroacridine polymorph, a corresponding crystal composition and pharmaceutical composition, and applications thereof. The compound succinic octahydroacridine is used for screening and studying polymorphs, and the discovered polymorphs are appraised and evaluated; crystal forms having better physical and chemical properties are determined for subsequent development and study, and crystal forms having good stability and an excellent therapeutic effect are obtained.

Inventors:
WANG TONGHUI (CN)
ZHANG JU (CN)
WANG LIHUA (CN)
WANG DEPU (CN)
ZHANG YAXIN (CN)
YU QINGHUA (CN)
ZHANG QI (CN)
LI MINGZE (CN)
Application Number:
PCT/CN2020/073389
Publication Date:
August 06, 2020
Filing Date:
January 21, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHANGCHUN HUAYUAN HIGH-SCIENCE AND TECH CO LTD (CN)
JIANGSU SHENERYANG HIGH-SCIENCE AND TECH CO LTD (CN)
International Classes:
C07D219/10; A61K31/473; A61P21/00; A61P21/04; A61P25/00; A61P25/18; A61P25/28; C07C51/43; C07C55/10
Domestic Patent References:
WO2002079166A12002-10-10
Foreign References:
CN1523016A2004-08-25
CN109734663A2019-05-10
CN109651248A2019-04-19
CN110683987A2020-01-14
CN109796405A2019-05-24
CN1523016A2004-08-25
Other References:
XIA ZHAO, YAN LIANG, JUNYU XU, DONGMEI ZHANG, DEPU WANG, JINGKAI GU, YIMIN CUI: "A single-center, randomized, open-label, dose-escalation study to evaluate the pharmacokinetics of tacrine analogue octahydrogenacridine succinate tablets in healthy Chinese subjects", BIOLOGICAL & PHARMACEUTICAL BULLETIN, vol. 35, no. 9, 31 December 2012 (2012-12-31), pages 1502 - 1508, XP055724299, ISSN: 0918-6158, DOI: 10.1248/bpb.b1200242
"Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING CO., pages: 1288 - 1300
"Handbook of Pharmaceutical Excipients", 1986, AMERICAN PHARMACEUTICAL ASSOCIATION & THE PHARMACEUTICAL SOCIETY OF GREAT BRITAIN, pages: 81 - 90
S. BYRN ET AL., PHARMACEUTICAL SOLIDS: A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS, PHARMACEUTICAL RESEARCH, vol. 12, no. 7, 1995, pages 945 - 954
J. K. HALEBLIANW. MCCRONE: "Pharmaceutical Applications of Polymorphism", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 58, no. 8, 1969, pages 911 - 929
CONG WEI-HONGLIU JIAN-XUN: "Progress in the study of animal models of Alzheimer's disease", CHINESE PHARMACOLOGICAL BULLETIN, vol. 19, no. 5, 2003, pages 497 - 501
SHEN YU-XIANYANG JUNWEI WEI ET AL.: "Learning and memory dysfunction in rats induced by beta-amyloid peptide fragment 25-35", CHINESE PHARMACOLOGICAL BULLETIN, vol. 17, no. 1, 2001, pages 26 - 19
LIN YUCHEN JUNPAOXU BIN ET AL.: "Study of rats with beta-amyloid injection into hippocampus to establish a memory impairment model", CHIN J PSYCHIATRY, vol. 33, no. 4, 2000, pages 222 - 225
ZHAO XIAN-LINFANG XIU-BINLI DONG-PEI: "Establishment of Vascular Dementia Model in Rats", J CHIN MED UNIV, vol. 31, no. 3, 2002, pages 166 - 168
WANG YONG-YANZHANG BO-LI: "Modern Chinese Medicine Clinic and Research on Vascular Dementia", vol. 214, October 2003, PEOPLE'S MEDICAL PUBLISHING HOUSE, article "Editor-in-chief"
See also references of EP 3912971A4
Attorney, Agent or Firm:
BEIJING GEYUN INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: